Davidson, Matthew D.
Ballinger, Kimberly R.
Khetani, Salman R.
Article History
Received: 30 January 2016
Accepted: 31 May 2016
First Online: 17 June 2016
Competing interests
: S.R.K. is an equity holder in Ascendance Biotechnology (previously Hepregen Corporation), which has licensed the MPCC technology from M.I.T. for drug development applications